TUDOR INVESTMENT CORP ET AL - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 177 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,657,045
+18.7%
101,972
+35.1%
0.01%
-11.1%
Q1 2024$1,395,773
-17.8%
75,488
-7.4%
0.01%
-47.1%
Q3 2023$1,698,523
+42.1%
81,503
-3.9%
0.02%
-45.2%
Q2 2022$1,195,000
+11.2%
84,833
+84.2%
0.03%
+72.2%
Q4 2021$1,075,000
+188.2%
46,063
+104.9%
0.02%
+200.0%
Q3 2021$373,000
-55.7%
22,483
-31.1%
0.01%
-64.7%
Q1 2021$842,000
+267.7%
32,635
+663.4%
0.02%
+183.3%
Q4 2020$229,000
+10.6%
4,275
+0.3%
0.01%
-40.0%
Q2 2020$207,000
-89.2%
4,264
-90.5%
0.01%
-88.4%
Q4 2019$1,916,000
-60.7%
44,793
-66.9%
0.09%
-48.5%
Q3 2019$4,872,000
+377.6%
135,365
+114.6%
0.17%
+735.0%
Q4 2018$1,020,000
-23.8%
63,082
-28.1%
0.02%
-57.4%
Q2 2018$1,339,000
-14.3%
87,705
+69.1%
0.05%
+17.5%
Q4 2017$1,562,000
+232.3%
51,869
+207.9%
0.04%
+185.7%
Q2 2017$470,000
-8.6%
16,847
+17.0%
0.01%0.0%
Q4 2015$514,000
+1.4%
14,405
-6.0%
0.01%
-17.6%
Q3 2015$507,000
-36.1%
15,327
-19.2%
0.02%
-26.1%
Q2 2015$794,000
+198.5%
18,969
+76.5%
0.02%
+130.0%
Q3 2014$266,00010,7480.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 647,833$26,723,00011.32%
GREAT POINT PARTNERS LLC 1,921,563$79,264,0007.13%
Baker Brothers Advisors 41,904,586$1,728,564,0006.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 486,000$20,048,0006.47%
Palo Alto Investors LP 1,832,300$75,582,0004.15%
Birchview Capital, LP 204,000$8,416,0002.81%
SECTORAL ASSET MANAGEMENT INC 556,514$22,956,0001.97%
Rock Springs Capital Management LP 1,573,200$64,895,0001.65%
Riggs Asset Managment Co. Inc. 17,470$2,025,0000.85%
PFM Health Sciences, LP 421,087$17,370,0000.80%
View complete list of ACADIA PHARMACEUTICALS INC shareholders